Pricing Log in Create free account

NewcelX Ltd. (NCEL) vs Pluri Inc. (PLUR)

NewcelX Ltd. and Pluri Inc. are both Biotechnology companies. NewcelX Ltd. and Pluri Inc. are of similar size ($15.6M and $15.0M). NewcelX Ltd. has the higher net margin (0.00% vs −2,344.6%) and the higher return on invested capital (0.00% vs −526.9%). Across the 12 metrics below, NewcelX Ltd. leads on 7 and Pluri Inc. on 5.

Valuation

Metric NCEL PLUR Biotechnology median
P/E n/m n/m 10.60
P/S n/m 11.89 9.40
P/B 5.02 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 31.96 9.02
Earnings yield (56.25%) (197.58%) (32.88%)
Free cash flow yield (16.18%) (167.21%) (23.13%)

Profitability

Metric NCEL PLUR Biotechnology median
Gross margin 0.00% 44.59% 68.51%
Operating margin — (2,454.53%) 0.00%
Net margin 0.00% (2,344.59%) 0.00%
Free cash flow margin 0.00% (1,988.48%) 0.00%
Return on equity 0.00% 260.35% (51.96%)
Return on assets 0.00% (74.95%) (46.06%)
Return on invested capital 0.00% (526.92%) 0.00%

Growth

Metric NCEL PLUR Biotechnology median
Revenue growth (TTM) — (23.95%) 6.76%
EPS growth (last fiscal year) 11.18% 31.46% 29.88%
Revenue growth, 5-year CAGR — 113.32% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NCEL PLUR Biotechnology median
Debt to equity 0.06 (1.62) 0.00
Current ratio 0.40 0.27 4.97
Net debt to EBITDA 0.74 (0.83) 1.01

Dividend

Metric NCEL PLUR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NCEL PLUR Biotechnology median
Market cap 15.56m 15.00m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack